Monograph Details
|
|
Hematology
> Anemias
|
|
FERRLECIT |
| Manufacturer |
|
Watson Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Hematinic. |
| Generic Name |
|
Iron (as sodium ferric gluconate complex in sucrose) 12.5mg/mL; soln for IV inj or infusion; contains benzyl alcohol. |
| Indications |
|
Iron deficiency anemia in patients on chronic hemodialysis receiving epoetin therapy. |
| Children |
|
<6 yrs: not recommended. Give by IV infusion (diluted) over 1 hour. ≥6yrs: 1.5mg/kg per dose at 8 sequential dialysis sessions; max: 125mg/dose. |
| Adults |
|
Give by IV infusion (diluted) or slow IV inj (undiluted). 125mg infused over 1 hour or by slow IV inj (at a rate of up to 12.5mg/min). Minimum cumulative dose: 1g given over 8 sequential dialysis sessions; usual max: 125mg/dose. |
| Contraindications |
|
Anemias not caused by iron deficiency. Iron overload. Neonates. |
| Precautions |
|
Hemoglobinopathies. Refractory anemias. Pregnancy (Cat. B). Nursing mothers. |
| Interactions |
|
May reduce absorption of concomitant oral iron preparations. |
| Adverse Reactions |
|
Hypotension, hypertension, GI upset, chest pain, back pain, abdominal pain, pruritus, inj site reaction, headache, dizziness, syncope, fatigue, fever, cramps, dyspnea, tachycardia; rare: hypersensitivity reactions. |
| How Supplied |
|
Ampules (5mL)—10 |
|
|
|
|
